Group One Trading
SCLN

Group One Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Group One Trading’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,000
Closed -$43K – 5304
2016
Q4 		$43K Sell
4,000
-9,300
-70% -$93K ﹤0.01% 3346
2016
Q3 		$136K Buy
+13,300
New +$145K ﹤0.01% 2744
2016
Q2 		– Sell
-4,400
Closed -$48K – 5192
2016
Q1 		$48K Buy
4,400
+4,300
+4,300% +$38.2K ﹤0.01% 3279
2015
Q4 		$1K Hold
100
– – ﹤0.01% 4652
2015
Q3 		$1K Hold
100
– – ﹤0.01% 4796
2015
Q2 		$1K Sell
100
-5,200
-98% -$47.4K ﹤0.01% 4779
2015
Q1 		$47K Sell
5,300
-27,200
-84% -$217K ﹤0.01% 3406
2014
Q4 		$285K Sell
32,500
-5,700
-15% -$46.1K ﹤0.01% 2009
2014
Q3 		$263K Buy
38,200
+36,400
+2,022% +$218K ﹤0.01% 2165
2014
Q2 		$9K Hold
1,800
– – ﹤0.01% 4569
2014
Q1 		$8K Buy
+1,800
New +$8.69K ﹤0.01% 4693
2013
Q3 		– Sell
-16,800
Closed -$83K – 5856
2013
Q2 		$83K Buy
+16,800
New +$79.9K ﹤0.01% 2988

Group One Trading's SCLN Position: Q4 2017 in Review

Group One Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 300 shares — an estimated $3K sold.

Group One Trading first reported a position in SCLN in Q2 2013 and held it in 5 quarters. The position peaked at $18K in Q1 2014. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Group One Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Group One Trading sold 300 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $3K.
  • Group One Trading first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Group One Trading's Sciclone Pharmaceuticals Inc position peaked at $18K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Group One Trading's 13F filing for Q4 2017, filed 9 Feb 2018.